Peter Francis

Statistics

Publications

Citations

410

H-Index

Active since

1992

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Peter Francis is an author at National Cancer Institute specializing in antifungal therapy, invasive aspergillosis treatment, and infectious diseases.

ORCID

Publications per year

1992–1994

Publications

Efficacy of Unilamellar Liposomal Amphotericin B in Treatment of Pulmonary Aspergillosis in Persistently Granulocytopenic Rabbits: The Potential Role of Bronchoalveolar D-Mannitol and Serum Galactomannan as Markers of Infection

Peter Francis, J W Lee, A. Hoffman et al. · The Journal of Infectious Diseases · 1994 · 185 citations

Medicine, Infectious Diseases, Pharmacology +17

Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits

J W Lee, Michael Amantea, Peter Francis et al. · Antimicrobial Agents and Chemotherapy · 1994 · 135 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis

Maria C. Allende, J W Lee, Peter Francis et al. · Antimicrobial Agents and Chemotherapy · 1994 · 69 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Approaches to management of fungal infections in cancer patients.

Peter Francis, Walsh Tj · PubMed · 1992 · 21 citations

Life Sciences, Infectious Diseases, Microbiology +17

1–4 of 4